Construct: ORF TRCN0000489338
Construct Description:
- Construct Type:
- ORF
- Other Identifiers:
- ORF019695.1_s317c1
- DNA Barcode:
- CTCATGACGTTAAATTTCAGTTAA
- Epitope Tag:
- V5
- Notes:
- No stop codon in insert
Originally Annotated References:
- Gene:
- MAPK8 (5599)
Vector Information:
- Vector Backbone:
- pLX_317
- Pol II Cassette 1:
- SV40-PuroR
- Pol II Cassette 2:
- EF1a-TRCN0000489338
- Selection Marker:
- PuroR
- Visible Reporter:
- n/a
- Epitope Tag:
- V5
Current transcripts matched by this ORF:
Taxon | Gene | Symbol | Description | Transcript | Nuc. Match %[?]A simple nucleotide-based global alignment percentage, calculated as follows: total nt. matches ---------------------------------- aligned length (incl. gaps) |
Prot. Match %[?]A simple amino acid-based global alignment percentage, calculated as follows: total aa. matches ---------------------------------- aligned length (incl. gaps) |
Match Diffs[?]This field may contain sequence annotations in HGVS format. For more information about HGVS annotations, please refer to the HGVS Quick Reference Guide. | |
---|---|---|---|---|---|---|---|---|
1 | human | 5599 | MAPK8 | mitogen-activated protein k... | NM_001323302.2 | 99.9% | 99.7% | 1152_1153insG |
2 | human | 5599 | MAPK8 | mitogen-activated protein k... | NM_001323324.2 | 99.9% | 99.7% | 1152_1153insG |
3 | human | 5599 | MAPK8 | mitogen-activated protein k... | NM_001323326.2 | 99.9% | 99.7% | 1152_1153insG |
4 | human | 5599 | MAPK8 | mitogen-activated protein k... | NM_001323327.2 | 99.9% | 99.7% | 1152_1153insG |
5 | human | 5599 | MAPK8 | mitogen-activated protein k... | NM_001323321.2 | 97.3% | 97.6% | (many diffs) |
6 | human | 5599 | MAPK8 | mitogen-activated protein k... | NM_001323325.2 | 97.3% | 97.6% | (many diffs) |
7 | human | 5599 | MAPK8 | mitogen-activated protein k... | NM_139046.4 | 97.3% | 97.6% | (many diffs) |
8 | human | 5599 | MAPK8 | mitogen-activated protein k... | XM_024448080.1 | 97.3% | 97.6% | (many diffs) |
9 | human | 5599 | MAPK8 | mitogen-activated protein k... | NM_001323328.2 | 89.1% | 88.7% | 1136_1137insAGCAC;1148_1281delinsG |
10 | human | 5599 | MAPK8 | mitogen-activated protein k... | NM_001323329.2 | 89.1% | 88.7% | 1136_1137insAGCAC;1148_1281delinsG |
11 | human | 5599 | MAPK8 | mitogen-activated protein k... | NM_001323331.2 | 89.1% | 88.7% | 1136_1137insAGCAC;1148_1281delinsG |
12 | human | 5599 | MAPK8 | mitogen-activated protein k... | NM_139049.4 | 89.1% | 88.7% | 1136_1137insAGCAC;1148_1281delinsG |
13 | human | 5599 | MAPK8 | mitogen-activated protein k... | NM_001278547.1 | 86.9% | 86.8% | (many diffs) |
14 | human | 5599 | MAPK8 | mitogen-activated protein k... | NM_001323322.2 | 86.9% | 86.8% | (many diffs) |
15 | human | 5599 | MAPK8 | mitogen-activated protein k... | NM_001323323.2 | 86.9% | 86.8% | (many diffs) |
16 | human | 5599 | MAPK8 | mitogen-activated protein k... | NM_001323330.2 | 86.9% | 86.8% | (many diffs) |
17 | human | 5599 | MAPK8 | mitogen-activated protein k... | XM_024448079.1 | 86.9% | 86.8% | (many diffs) |
18 | human | 5599 | MAPK8 | mitogen-activated protein k... | NM_001278548.1 | 80.1% | 80% | 615_616ins228;924_925insG |
19 | human | 5602 | MAPK10 | mitogen-activated protein k... | NM_001351625.2 | 79.7% | 92.2% | (many diffs) |
20 | human | 5602 | MAPK10 | mitogen-activated protein k... | XM_017008434.2 | 79.7% | 92.2% | (many diffs) |
21 | human | 5602 | MAPK10 | mitogen-activated protein k... | XM_017008435.2 | 79.7% | 92.2% | (many diffs) |
22 | human | 5602 | MAPK10 | mitogen-activated protein k... | XM_017008436.2 | 79.7% | 92.2% | (many diffs) |
23 | human | 5602 | MAPK10 | mitogen-activated protein k... | XM_017008437.2 | 79.7% | 92.2% | (many diffs) |
24 | human | 5602 | MAPK10 | mitogen-activated protein k... | NM_001363657.2 | 77.5% | 90.6% | (many diffs) |
25 | human | 5602 | MAPK10 | mitogen-activated protein k... | XM_017008441.2 | 73.7% | 86.2% | (many diffs) |
26 | human | 5602 | MAPK10 | mitogen-activated protein k... | NM_002753.5 | 72.5% | 83.9% | (many diffs) |
27 | human | 5602 | MAPK10 | mitogen-activated protein k... | XM_005263135.4 | 72.5% | 83.9% | (many diffs) |
28 | human | 5602 | MAPK10 | mitogen-activated protein k... | XM_017008429.2 | 72.5% | 83.9% | (many diffs) |
29 | human | 5602 | MAPK10 | mitogen-activated protein k... | XM_017008430.2 | 72.5% | 83.9% | (many diffs) |
30 | human | 5602 | MAPK10 | mitogen-activated protein k... | XM_017008432.2 | 72.5% | 83.9% | (many diffs) |
31 | human | 5602 | MAPK10 | mitogen-activated protein k... | XM_024454144.1 | 72.5% | 83.9% | (many diffs) |
32 | human | 5602 | MAPK10 | mitogen-activated protein k... | XM_024454145.1 | 72.5% | 83.9% | (many diffs) |
33 | human | 5602 | MAPK10 | mitogen-activated protein k... | XM_024454146.1 | 72.5% | 83.9% | (many diffs) |
34 | human | 5602 | MAPK10 | mitogen-activated protein k... | XM_024454147.1 | 72.5% | 83.9% | (many diffs) |
35 | human | 5599 | MAPK8 | mitogen-activated protein k... | NM_001323320.2 | 71.4% | 70.9% | 615_616ins228;908_909insAGCAC;920_1053delinsG |
36 | human | 5602 | MAPK10 | mitogen-activated protein k... | NM_001351624.2 | 71.3% | 82.1% | (many diffs) |
37 | human | 5602 | MAPK10 | mitogen-activated protein k... | NM_138980.4 | 71.3% | 82.1% | (many diffs) |
38 | human | 5602 | MAPK10 | mitogen-activated protein k... | XM_006714268.3 | 71.3% | 82.1% | (many diffs) |
39 | human | 5602 | MAPK10 | mitogen-activated protein k... | XM_011532120.3 | 71.3% | 82.1% | (many diffs) |
40 | human | 5602 | MAPK10 | mitogen-activated protein k... | XM_011532121.3 | 71.3% | 82.1% | (many diffs) |
41 | human | 5602 | MAPK10 | mitogen-activated protein k... | XM_017008423.2 | 71.3% | 82.1% | (many diffs) |
42 | human | 5602 | MAPK10 | mitogen-activated protein k... | XM_006714269.3 | 70.5% | 82.5% | (many diffs) |
43 | human | 5602 | MAPK10 | mitogen-activated protein k... | XM_017008433.2 | 65.9% | 76.7% | (many diffs) |
44 | human | 5602 | MAPK10 | mitogen-activated protein k... | NM_138982.4 | 65.5% | 75.4% | (many diffs) |
45 | human | 5602 | MAPK10 | mitogen-activated protein k... | XM_005263129.3 | 65.5% | 75.4% | (many diffs) |
46 | human | 5602 | MAPK10 | mitogen-activated protein k... | XM_005263130.3 | 65.5% | 75.4% | (many diffs) |
47 | human | 5602 | MAPK10 | mitogen-activated protein k... | XM_011532117.3 | 65.5% | 75.4% | (many diffs) |
48 | human | 5602 | MAPK10 | mitogen-activated protein k... | XM_011532118.3 | 65.5% | 75.4% | (many diffs) |
49 | human | 5602 | MAPK10 | mitogen-activated protein k... | XM_017008420.2 | 65.5% | 75.4% | (many diffs) |
50 | human | 5602 | MAPK10 | mitogen-activated protein k... | XM_024454139.1 | 65.5% | 75.4% | (many diffs) |
51 | human | 5602 | MAPK10 | mitogen-activated protein k... | XM_024454140.1 | 65.5% | 75.4% | (many diffs) |
52 | human | 5602 | MAPK10 | mitogen-activated protein k... | XM_024454141.1 | 65.5% | 75.4% | (many diffs) |
53 | human | 5602 | MAPK10 | mitogen-activated protein k... | XM_024454142.1 | 65.5% | 75.4% | (many diffs) |
54 | human | 5602 | MAPK10 | mitogen-activated protein k... | XM_024454143.1 | 65.5% | 75.4% | (many diffs) |
55 | human | 5602 | MAPK10 | mitogen-activated protein k... | XM_017008451.2 | 64.4% | 74% | (many diffs) |
56 | human | 5602 | MAPK10 | mitogen-activated protein k... | NM_001318069.2 | 63.6% | 75.4% | (many diffs) |
57 | human | 5602 | MAPK10 | mitogen-activated protein k... | XM_017008452.2 | 58.2% | 66.7% | (many diffs) |
58 | human | 5602 | MAPK10 | mitogen-activated protein k... | XM_017008445.2 | 57.6% | 65.7% | (many diffs) |
59 | human | 5602 | MAPK10 | mitogen-activated protein k... | XM_017008447.2 | 52% | 59.1% | (many diffs) |
60 | human | 5602 | MAPK10 | mitogen-activated protein k... | XM_017008448.2 | 52% | 59.1% | (many diffs) |
61 | human | 5602 | MAPK10 | mitogen-activated protein k... | XM_017008454.2 | 39% | 46.3% | (many diffs) |
62 | human | 5602 | MAPK10 | mitogen-activated protein k... | XM_024454149.1 | 39% | 46.3% | (many diffs) |
63 | human | 5602 | MAPK10 | mitogen-activated protein k... | XM_017008453.2 | 38.9% | 46.5% | (many diffs) |
64 | human | 5599 | MAPK8 | mitogen-activated protein k... | NR_136583.2 | 19.7% | 1_194del;1063_1064insAGCC;1343_5810delinsG | |
65 | human | 5599 | MAPK8 | mitogen-activated protein k... | NR_136584.2 | 19.6% | (many diffs) | |
66 | human | 5599 | MAPK8 | mitogen-activated protein k... | NR_136585.2 | 19.3% | (many diffs) | |
67 | mouse | 26419 | Mapk8 | mitogen-activated protein k... | NM_016700.4 | 94% | 99.7% | (many diffs) |
68 | mouse | 26419 | Mapk8 | mitogen-activated protein k... | NM_001310452.1 | 91.5% | 97.6% | (many diffs) |
69 | mouse | 26419 | Mapk8 | mitogen-activated protein k... | XM_006519032.3 | 91.5% | 97.6% | (many diffs) |
70 | mouse | 26419 | Mapk8 | mitogen-activated protein k... | NM_001310454.1 | 84% | 88.7% | (many diffs) |
71 | mouse | 26419 | Mapk8 | mitogen-activated protein k... | NM_001310453.1 | 81.8% | 86.8% | (many diffs) |
72 | mouse | 26414 | Mapk10 | mitogen-activated protein k... | XM_017320890.2 | 77.7% | 92.2% | (many diffs) |
73 | mouse | 26414 | Mapk10 | mitogen-activated protein k... | XM_017320891.2 | 77.7% | 92.2% | (many diffs) |
74 | mouse | 26414 | Mapk10 | mitogen-activated protein k... | XM_030254519.1 | 75.8% | 91.1% | (many diffs) |
75 | mouse | 26414 | Mapk10 | mitogen-activated protein k... | XM_017320888.2 | 69.6% | 82.1% | (many diffs) |
76 | mouse | 26414 | Mapk10 | mitogen-activated protein k... | XM_006534950.4 | 69% | 82.9% | (many diffs) |
77 | mouse | 26414 | Mapk10 | mitogen-activated protein k... | XM_030254516.1 | 63.9% | 75.4% | (many diffs) |
Sequence Information
Note: uppercase bases indicate empirically verified sequence.
- ORF start:
- 75
- ORF end:
- 1230
- ORF length:
- 1155
- Sequence:
-
1 tcttccattt caggtgtcgt gaggctagca tcgattgatc aacaagtttg tacaaaaaag 61 caggcttcgc caccatgagc agaagcaagc gtgacaacaa tttttatagt gtagagattg 121 gagattctac attcacagtc ctgaaacgat atcagaattt aaaacctata ggctcaggag 181 ctcaaggaat agtatgcgca gcttatgatg ccattcttga aagaaatgtt gcaatcaaga 241 agctaagccg accatttcag aatcagactc atgccaagcg ggcctacaga gagctagttc 301 ttatgaaatg tgttaatcac aaaaatataa ttggcctttt gaatgttttc acaccacaga 361 aatccctaga agaatttcaa gatgtttaca tagtcatgga gctcatggat gcaaatcttt 421 gccaagtgat tcagatggag ctagatcatg aaagaatgtc ctaccttctc tatcagatgc 481 tgtgtggaat caagcacctt cattctgctg gaattattca tcgggactta aagcccagta 541 atatagtagt aaaatctgat tgcactttga agattcttga cttcggtctg gccaggactg 601 caggaacgag ttttatgatg acgccttatg tagtgactcg ctactacaga gcacccgagg 661 tcatccttgg catgggctac aaggaaaacg tggatttatg gtctgtgggg tgcattatgg 721 gagaaatggt ttgccacaaa atcctctttc caggaaggga ctatattgat cagtggaata 781 aagttattga acagcttgga acaccatgtc ctgaattcat gaagaaactg caaccaacag 841 taaggactta cgttgaaaac agacctaaat atgctggata tagctttgag aaactcttcc 901 cTGATGTCCT TTTCCCAGCT GACTCAGAAC ACAACAAACT TAAAGCCAGT CAGGCAAGGG 961 ATTTGTTATC CAAAATGCTG GTAATAGATG CATCTAAAAG GATCTCTGTA GATGAAGCTC 1021 TCCAACACCC GTACATCAAT GTCTGGTATG ATCCTTCTGA AGCAGAAGCT CCACCACCAA 1081 AGATCCCTGA CAAGCAGTTA GATGAAAGGG AACACACAAT AGAAGAGTGG AAAGAATTGA 1141 TATATAAGGA AGTTATGGAC TTGGAGGAGA GAACCAAGAA TGGAGTTATA CGGGGGCAGC 1201 CCTCTCCTTT AGCACAGGTG CAGCAGGACC CAGCTTTCTT GTACAAAGTG GTTGATATCG 1261 GTAAGCCTAT CCCTAACCCT CTCCTCGGTC TCGATTCTAC GTAGTAATGA ACTAGTCCGT 1321 AACTTGAAAG TATTTCGATT TCTTGGCTTT ATATATCTTG TGGAAAGGAC GACTCATGAC 1381 GTTAAATTTC AGTTAAACGC GTTAAGTCga caatcaacct ctggattaca aaatttgtga 1441 aagatt